Cargando…

Cost-efficacy analysis of 3% diclofenac sodium, ingenol mebutate, and 3.75% imiquimod in the treatment of actinic keratosis

Actinic keratosis (AK) is a clinical condition characterized by keratinocytic dysplastic lesions of the epidermis, affecting individuals chronically exposed to sunlight. Topical therapies allow the treatment of a whole area of affected skin and currently include diclofenac sodium gel, 5-fluorouracil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nisticò, Steven, Del Duca, Ester, Torchia, Valeria, Gliozzi, Micaela, Bottoni, Ugo, Muscoli, Carolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849248/ https://www.ncbi.nlm.nih.gov/pubmed/29442526 http://dx.doi.org/10.1177/2058738418757925

Ejemplares similares

Ingenol mebutate: A novel topical drug for actinic keratosis
por: Aditya, Suruchi, et al.
Publicado: (2013)

New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel
por: Berman, Brian
Publicado: (2012)

Ingenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients
por: Joe, Hyun Jae, et al.
Publicado: (2017)

Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics
por: Campione, Elena, et al.
Publicado: (2016)

Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp
por: Skroza, Nevena, et al.
Publicado: (2017)

Ingenol mebutate treatment in actinic keratosis – clinical effectiveness and potential side effects
por: Lesiak, Aleksandra, et al.
Publicado: (2019)

Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice
por: Skroza, Nevena, et al.
Publicado: (2018)

Identification of differentially expressed genes in actinic keratosis samples treated with ingenol mebutate gel
por: Segura, Sonia, et al.
Publicado: (2020)

Willingness-to-pay to access Ingenol Mebutate Gel for Actinic Keratosis Treatment in the U.S. Setting
por: Willis, Michael, et al.
Publicado: (2014)

Ingenol mebutate treatment in keloids
por: De Felice, Bruna, et al.
Publicado: (2015)

Tattoo removal with ingenol mebutate
por: Cozzi, Sarah-Jane, et al.
Publicado: (2017)

The Role of Ingenol Mebutate in the Treatment of Actinic Keratoses
por: Ali, Faisal R., et al.
Publicado: (2012)

Dermoscopy and Reflectance Confocal Microscopy for Monitoring the Treatment of Actinic Keratosis with Ingenol Mebutate Gel: Report of Two Cases
por: Longo, Caterina, et al.
Publicado: (2016)

Imiquimod 3.75% for field‐directed therapy of actinic keratosis: results of a prospective case‐series study in Greece
por: Befon, Angeliki, et al.
Publicado: (2019)

Recurrent In Situ Melanoma Successfully Treated with Ingenol Mebutate
por: Mansuy, Marion, et al.
Publicado: (2014)

Pronounced local skin reaction to ingenol mebutate against actinic keratosis in kidney transplant recipient without systemic adverse events
por: Mohanna, Mosab, et al.
Publicado: (2015)

A New, Objective, Quantitative Scale for Measuring Local Skin Responses Following Topical Actinic Keratosis Therapy with Ingenol Mebutate
por: Rosen, Robert, et al.
Publicado: (2014)

IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate
por: Le, Thuy T., et al.
Publicado: (2016)

Ingenol Mebutate: A Succinct Review of a Succinct Therapy
por: Alchin, David Rhys
Publicado: (2014)

Multipuncture technique with ingenol mebutate in the treatment of a periungual wart
por: Dellatorre, Gerson, et al.
Publicado: (2018)

Acantholytic Pityriasis Rubra Pilaris Associated with Imiquimod 3.75% Application
por: Atanaskova Mesinkovska, Natasha, et al.
Publicado: (2011)

Assessment of local skin reactions with a sequential regimen of cryosurgery followed by ingenol mebutate gel, 0.015%, in patients with actinic keratosis
por: Goldenberg, Gary, et al.
Publicado: (2014)

Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series
por: Bobyr, Ivan, et al.
Publicado: (2016)

Field cancerization therapy with ingenol mebutate contributes to restoring skin-metabolism to normal-state in patients with actinic keratosis: a metabolomic analysis
por: Righi, Valeria, et al.
Publicado: (2019)

Earliest stage treatment of actinic keratosis with imiquimod 3.75% cream: Two case reports—Perspective for non melanoma skin cancer prevention
por: Kopera, Daisy
Publicado: (2020)

Synthesis and Cytotoxicity against K562 Cells of 3-O-Angeloyl-20-O-acetyl Ingenol, a Derivative of Ingenol Mebutate
por: Liu, Ming, et al.
Publicado: (2016)

Topical ingenol mebutate is effective against plantar warts in immunocompromised patients
por: Mrad, Marc, et al.
Publicado: (2017)

Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects
por: Saraiva, Maria Isabel Ramos, et al.
Publicado: (2018)

A Case of Bowen's Disease Successfully Treated with Ingenol Mebutate Gel
por: Chae, Je-Byeong, et al.
Publicado: (2017)

A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body
por: Pellacani, G., et al.
Publicado: (2015)

A trial‐based cost‐effectiveness analysis of topical 5‐fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands
por: Jansen, M.H.E., et al.
Publicado: (2020)

Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod()()
por: Rovesti, Miriam, et al.
Publicado: (2021)

Treatment of superficial basal cell carcinoma with ingenol mebutate gel, 0.05%
por: Bettencourt, Miriam S
Publicado: (2016)

Repeated Treatments with Ingenol Mebutate Prevents Progression of UV-Induced Photodamage in Hairless Mice
por: Erlendsson, Andrés Már, et al.
Publicado: (2016)

A Case of New-Onset Pemphigus Erythematosus after Topical Application of Ingenol Mebutate
por: Yang, Hee Joo, et al.
Publicado: (2021)

Immunothrombotic Mechanisms Induced by Ingenol Mebutate Lead to Rapid Necrosis and Clearance of Anogenital Warts
por: Braun, Stephan A., et al.
Publicado: (2022)

Complete response of locally advanced cutaneous squamous cell carcinoma of the eyelid to topical imiquimod 3.75%
por: Toso, Francesco, et al.
Publicado: (2022)

Superficial Basal Cell Carcinoma Treated with Two Cycles of Ingenol Mebutate Gel 0.015%
por: Jung, Yu Seok, et al.
Publicado: (2016)

Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate
por: Emmert, Steffen, et al.
Publicado: (2016)

miR-34 modulates apoptotic gene expression in Ingenol mebutate treated keloid fibroblasts
por: De Felice, Bruna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4d4p3fnoaj32bfsqneooofgdvf